相关实验视频

Updated: May 20, 2025

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

在膀尿癌中AHCY表达的作用:生物信息学和实验分析

Shaorui Niu¹, Xiaozhe Zheng¹, Yuyang Yao¹

¹Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Central Laboratory, The First Hospital of Nanchang, The Third Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.

Cancer management and research

|March 27, 2025

概括

在膀癌中,腺基氨酸酶 (AHCY) 的高调,与较差的生存率相关. 抑制AHCY抑制了瘤生长和转移,这表明AHCY是膀泌尿腺癌 (BLCA) 的潜在治疗标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

腺赛尔homocysteinase (AHCY) 与瘤发生有关,但其在膀泌尿细胞癌 (BLCA) 中的作用尚不清楚.
了解AHCY的功能对于开发针对BLCA的向疗法至关重要.

研究的目的:

为了研究BLCA中的AHCY表达模式.
为了确定AHCY在BLCA患者的预后意义.
探索AHCY在BLCA中的功能作用和免疫相关性.

主要方法:

在BLCA中使用癌症基因组图谱 (TCGA) 数据库分析AHCY表达的分析.
卡普兰-梅尔和COX回归分析用于生存评估.
使用si-RNA抑制AHCY并评估细胞效应的体外研究 (qRT-PCR,CCK-8,scratch,Transwell测定).

主要成果:

与正常组织相比,BLCA组织中的AHCY表达是上调的.
较高的AHCY表达与总生存率降低,晚期临床阶段,N阶段和T阶段相关.
在体外,AHCY抑制抑制了BLCA细胞的生长,迁移和入侵.
AHCY与rRNA代谢,细胞循环调节,m6A相关基因和免疫细胞透 (Th2,T-gd) 有关.

结论:

AHCY在BLCA进展和患者预后方面发挥着重要作用.
AHCY代表了膀泌尿道癌的潜在诊断和治疗标.
对AHCY机制的进一步研究可以推进BLCA治疗策略.

关键词:

它们是adenosylhomocysteinase.生物标志物生物标志物膀泌尿细胞癌膀泌尿细胞癌免疫透免疫透是什么?预后预后预后

更多相关视频

Expression of Transgenes in Native Bladder Urothelium Using Adenovirus-Mediated Transduction

Expression of Transgenes in Native Bladder Urothelium Using Adenovirus-Mediated Transduction

Published on: October 6, 2022

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

相关概念视频